Evidence database / Studies / aslanides-2015-amaris-high-myopia-transprk-prk-lasik
MODERATE evidencePROSPECTIVE COHORTVerified evidence
Single-Step Transepithelial ASLA (SCHWIND) With Mitomycin-C for the Correction of High Myopia: Long-Term Follow-Up
Ioannis M. Aslanides, Panagiotis N. Georgoudis, Vasilis D. Selimis, Achyut N. Mukherjee · Clinical Ophthalmology · 2015
—enrolled patients*
101enrolled eyes*
3structured arms
365maximum standardized days follow-up
* Descriptive sum of reported arm counts. “≥” indicates that one or more arm counts were not reported; missing values are not treated as zero.
Study arm
Single-step ASLA TransPRK
TransPRKAMARIS
Population
- Patients
- Not reported
- Eyes
- 41
- Bilateral treatment
- Not reported
- Age range
- Not reported
- Sphere range
- Not reported
- Cylinder range
- Not reported
- Spherical equivalent
- Not reported
- Corneal thickness
- Not reported
Eligibility definition
Inclusion
Myopia greater than 6.00 D with astigmatism below 3.50 D.
Exclusion
Not structured
Reported outcomes by follow-up
| Outcome | Follow-up | Follow-up sample | Result | Reported fraction | Provenance |
|---|---|---|---|---|---|
| MRSE within ±0.50 D predictability | 12 months | 41 eyes | 91.4% | denominator: 41 eyes | VERIFIED |
| Mean postoperative spherical equivalent refractive | 12 months | 41 eyes | -0.10 D | denominator: 41 eyes | VERIFIED |
| Mean uncorrected distance visual acuity efficacy | 12 months | 41 eyes | 0.000 logMAR | denominator: 41 eyes | VERIFIED |
Complications
No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.
Study arm
Alcohol-assisted PRK
PRKAMARIS
Population
- Patients
- Not reported
- Eyes
- 29
- Bilateral treatment
- Not reported
- Age range
- Not reported
- Sphere range
- Not reported
- Cylinder range
- Not reported
- Spherical equivalent
- Not reported
- Corneal thickness
- Not reported
Eligibility definition
Inclusion
Matched high-myopia control eyes; myopia greater than 6.00 D with astigmatism below 3.50 D.
Exclusion
Not structured
Reported outcomes by follow-up
| Outcome | Follow-up | Follow-up sample | Result | Reported fraction | Provenance |
|---|---|---|---|---|---|
| MRSE within ±0.50 D predictability | 12 months | 29 eyes | 85.7% | denominator: 29 eyes | VERIFIED |
| Mean postoperative spherical equivalent refractive | 12 months | 29 eyes | -0.20 D | denominator: 29 eyes | VERIFIED |
| Mean uncorrected distance visual acuity efficacy | 12 months | 29 eyes | 0.060 logMAR | denominator: 29 eyes | VERIFIED |
Complications
No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.
Study arm
LASIK
LASIKAMARIS
Population
- Patients
- Not reported
- Eyes
- 31
- Bilateral treatment
- Not reported
- Age range
- Not reported
- Sphere range
- Not reported
- Cylinder range
- Not reported
- Spherical equivalent
- Not reported
- Corneal thickness
- Not reported
Eligibility definition
Inclusion
Matched high-myopia control eyes; myopia greater than 6.00 D with astigmatism below 3.50 D.
Exclusion
Not structured
Reported outcomes by follow-up
| Outcome | Follow-up | Follow-up sample | Result | Reported fraction | Provenance |
|---|---|---|---|---|---|
| MRSE within ±0.50 D predictability | 12 months | 31 eyes | 83.9% | denominator: 31 eyes | VERIFIED |
| Mean postoperative spherical equivalent refractive | 12 months | 31 eyes | -0.08 D | denominator: 31 eyes | VERIFIED |
| Mean uncorrected distance visual acuity efficacy | 12 months | 31 eyes | 0.050 logMAR | denominator: 31 eyes | VERIFIED |
Complications
No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.